The cell therapy field is shifting its focus towards commercial success. Attention is turning to novel innovations like in vivo therapies and automated manufacturing; two game-changing strategies that promise to cut costs, speed up development, and unlock commercial viability. With cautious optimism returning and investors re-engaging with over $6.6 Billion invested in the last six months from the likes of AbbVie and Kite, it’s critical to adapt to this next wave of innovation where standout clinical data and scalable platforms are non-negotiable.

The 11th CAR TCR Summit is your must attend forum, bringing together the latest scientific innovation across therapeutic classes and indications to inform your business strategy and support long term commercial success. Renowned for its calibre of networking opportunities and unparalleled depth of content, expect cutting-edge clinical data on both ex vivo and in vivo advances, clinical trial strategies to support expanded patient access across indications, scalable and automated manufacturing processes to improve speed and costs, as well as commercial reflections to learn from those on the market.